The 20 Best Chromophobe Renal Cell Carcinoma Doctors Near Me in New York, NY

Paul Russo is a Urologist practicing medicine in New York, New York. Dr. Russo is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Wilms Tumor, Nephrectomy, and Reconstructive Urology Surgery. Dr. Russo is currently accepting new patients.

Martin Voss is an Oncologist practicing medicine in New York, New York. Dr. Voss is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Clear Cell Sarcoma, and Nephrectomy. Dr. Voss is currently accepting new patients.

Jonathan Coleman is a Urologist practicing medicine in New York, New York. Dr. Coleman is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Prostatectomy. Dr. Coleman is currently accepting new patients.

Abraham Hakimi is a Urologist practicing medicine in New York, New York. Dr. Hakimi is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery. Dr. Hakimi is currently accepting new patients.

Robert Motzer is an Oncologist practicing medicine in New York, New York. Dr. Motzer is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Teratoma of the Mediastinum, Nephrectomy, and Orchiectomy. Dr. Motzer is currently accepting new patients.

John Sfakianos is a Urologist practicing medicine in Astoria, New York. Dr. Sfakianos is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 36 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Sfakianos is currently accepting new patients.

Ketan Badani is a Urologist practicing medicine in New York, New York. Dr. Badani is rated as an Elite provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Prostate Cancer, Nephrectomy, and Prostatectomy.

Lee Richstone, MD is the Chairman of Urology and Director of Urology Services for the Western Region. He is also Director of Laparoscopic and Robotic Surgery at Lenox Hill Hospital and System Vice Chairman for Education for Northwell Health Urology. Dr. Richstone is Professor of Urology at The Hofstra-Northwell School of Medicine. Dr. Richstone completed medical school at the Cornell University Medical College in New York City. There he won early acceptance into Alpha Omega Alpha (AOA), the prestigious national medical honor society. He pursued his urologic training and chief residency at New York Presbyterian (Weill-Cornell) and Memorial Sloan Kettering hospitals. Dr. Richstone completed his fellowship training in urologic laparoscopic and robotic surgery and joined the North Shore Long Island Jewish Health System in 2007 as Director of Laparoscopic and Robotic Surgery. He then served as Chief of Urology for the North Shore University Hospital, then Chief of Urology at the Long Island Jewish Medical Center, before assuming the role of Chairman of Urology at Lenox Hill Hospital in Manhattan. Dr. Richstone is an internationally recognized urologic surgeon who has helped pioneer laparoscopic and robotic surgery for cancer of the prostate, kidney and bladder, as well as for various forms of urinary obstructions. He has over 90 peer-reviewed publications in leading national and international journals including The Journal of Urology, Urology, The British Journal of Urology, The Journal of Endourology, Cancer, and Cell.Dr. Richstone is a robotic surgery specialist having performed well over 1000 operations. This includes surgeries for prostate, kidney and bladder cancer and complex neobladder reconstructions completely robotically. His focus is on preserving urinary continence and sexual function. Dr. Richstone has also pioneered Laparoendoscopic Single Site Surgery (LESS), where entire laparoscopic operations are performed only through the belly button. Dr. Richstone is one of only a few surgeons in the United States to have performed single site partial nephrectomy and prostatectomy.Dr. Richstone is a member of the Society of Urologic Oncology (SUO), the America Urological Association (AUA), and the Endourological Society (EUS). Dr. Richstone is the recipient of numerous honors and awards, including acceptance into Alpha Omega Alpha (AOA), the E. Darracott Vaughan Prize for Excellence in Urology (2000), The Ferdinand C. Valentine Urology Essay Prize (First Place, 2005), The American Urological Association-Ambrose Reed Socioeconomic Essay Contest (First Place, 2005), and the Weill-Cornell Distinguished House Officer Award (2005). Dr. Richstone was awarded the Stryker and Nagamatsu Fellowship (2007), and won first prize at the Endourology Society Fellowship Paper Award the same year. Dr. Richstone won first prize at the AUA Research Foundation for Outstanding Research awarded at the 2010 AUA National Meeting in San Francisco. Dr. Richstone is rated as an Advanced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Muscle Invasive Bladder Cancer, Cystectomy, and Nephrectomy. Dr. Richstone is board certified in American Board Of Urology.

Thomas Bradley, MD, FACP, is Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. As System Head for Genitourinary Cancers for the Northwell Health Cancer Institute, Dr. Bradley has special expertise in the management of prostate, kidney, bladder, and testicular cancers. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Bradley maintains an active practice where he focusses on providing compassionate, personalized, evidence-based multi-disciplinary care. Dr. Bradley has a keen interest in the education of future physicians as evidenced by his directorship of the Fellowship program in Hematology and Medical Oncology for many years. His research work as principal investigator for numerous drug trials and multiple collaborations has resulted in dozens of publications and abstracts. Dr. Bradley earned his medical degree from the University of Monterrey School of Medicine. He trained in internal medicine as well as hematology and medical oncology at the State University of New York at Downstate Medical Center. Dr. Bradley is an active member of the American Society of Hematology, American Society of Clinical Oncology, American Association for Cancer Research and the American College of Physicians. Dr. Bradley is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Upper Tract Urothelial Carcinoma (UTUC), WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, Clear Cell Sarcoma, and Bone Marrow Aspiration. Dr. Bradley is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Arjun Balar is an Oncologist practicing medicine in New York, New York. Dr. Balar is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Prostate Cancer, Muscle Invasive Bladder Cancer, and Thrombectomy.

Daniel Cho is an Oncologist practicing medicine in New York, New York. Dr. Cho is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 15 other conditions, according to our data. His clinical expertise encompasses Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Familial Wilms Tumor 2, and Renal Cell Carcinoma (RCC).

William Huang is a Urologist practicing medicine in New York, New York. Dr. Huang is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery.

James Wysock is a Urologist practicing medicine in New York, New York. Dr. Wysock is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Urachal Cyst, Renal Cell Carcinoma (RCC), Nephrectomy, and Prostatectomy.

David Nanus is an Oncologist practicing medicine in Brooklyn, New York. He has been practicing medicine for over 44 years. Dr. Nanus is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Renal Cell Carcinoma (RCC), Familial Prostate Cancer, Orchiectomy, and Tissue Biopsy. Dr. Nanus is currently accepting new patients.

Michael Palese is a Urologist practicing medicine in New York, New York. Dr. Palese is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 42 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Enlarged Prostate (BPH), Clear Cell Sarcoma, Nephrectomy, and Reconstructive Urology Surgery. Dr. Palese is currently accepting new patients.

Jocelyn Wozney is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Wozney is rated as an Experienced provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. She is also highly rated in 22 other conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Paget Disease of the Breast, Breast Cancer, Familial Pancreatic Cancer, and Bone Marrow Aspiration. Dr. Wozney is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Joseph Del Pizzo is a Urologist practicing medicine in New York, New York. Dr. Del Pizzo is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Chromophobe Renal Cell Carcinoma, Renal Cell Carcinoma (RCC), WT1-Related Wilms Tumor Syndromes, Reconstructive Urology Surgery, and Nephrectomy. Dr. Del Pizzo is currently accepting new patients.

Timothy Mcclure is a Urologist practicing medicine in New York, New York. Dr. Mcclure is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Prostate Cancer, Empyema, Prostatic Artery Embolization, and Liver Embolization.

Guido Dalbagni is a Urologist practicing medicine in New York, New York. Dr. Dalbagni is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Upper Tract Urothelial Carcinoma (UTUC), Cystectomy, and Nephrectomy.

Alvin Goh is a Urologist practicing medicine in New York, New York. Dr. Goh is rated as a Distinguished provider by MediFind in the treatment of Chromophobe Renal Cell Carcinoma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Congenital Giant Megaureter, Cystectomy, and Nephrectomy. Dr. Goh is currently accepting new patients.